Skip to content

Study to investigate the effect of continuous intake on physiological changes --double-blind parallel-group comparative study--

Study to investigate the effect of continuous intake on physiological changes --double-blind parallel-group comparative study-- - Study to investigate the effect of continuous intake on physiological changes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043151
Enrollment
90
Registered
2021-05-31
Start date
2021-01-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Take 2 tablets of test food daily with water after breakfast Take 2 tablets of placebo daily with water after breakfast

Sponsors

IMEQRD inc.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 30 and 70 years 2. Japanese male or female 3. Participants who are able to input electronic diary with smartphone / PC. 4. Those who received sufficient explanation about the trial, volunteered to participate after understanding the purpose, and agree to participate in the trial with written consent.

Exclusion criteria

Exclusion criteria: 1. treated with some immunosuppressant, anticancer drug, or drugs that affect immune function 2. under diet or exercise therapy under the supervision of a doctor 3. current or history of serious disease 4. taking lactic acid bacteria products and bifidobacteria products regularly 5. consumption of quasi-drug, food for specified health use, heatlh food or supplement (subjects who can stop taking those after providing consent are acceptable) 6. treatment for serious drug allergies or food allergies 7. participation in another clinical trial within one month before providing consent, participating currently or planning to participate 8. planning to significantly change their lifestyle (diet, sleep, exercise, etc.) during the trial 9. planning to go to abroad 10. pregnant or lactating, or willing to be pregnant during the trial 11. judged by the investigator to be unsuitable for participating in this study

Design outcomes

Primary

MeasureTime frame
Physical condition questionnaire Physiological function evaluation questionnaire

Secondary

MeasureTime frame
Immune markers Body temperature

Countries

Japan

Contacts

Public ContactHirokuni Kayama

IMEQRD Co., Ltd. Planning and Sales Department

clinical-trial@imeqrd.co.jp03-6704-5968

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026